The CRISPR-Cas9 gene editing system helps restore lung cancer sensitivity to chemotherapy, stated study published today in the journal Molecular Therapy Oncolytics by scientists from The Gene Editing Institute of the Helen F. Graham Cancer Center (and) Research Institute at Christiana Care Health System.
The study reports that in both tissue culture and in a mouse, tumor growth stopped and there was a dramatic decrease in the volume of existing tumors when chemotherapy was combined with CRIPSP-Cas9, ...
The CRISPR-Cas9 gene editing system helps restore lung cancer sensitivity to chemotherapy, stated study published today in the journal Molecular Therapy Oncolytics by scientists from The Gene Editing Institute of the Helen F. Graham Cancer Center (and) Research Institute at Christiana Care Health System.
The study reports that in both tissue culture and in a mouse, tumor growth stopped and there was a dramatic decrease in the volume of existing tumors when chemotherapy was combined with CRIPSP-Cas9, ...